134 related articles for article (PubMed ID: 22169282)
41. The comparative analysis of serum proteomes for the discovery of biomarkers for acute myeloid leukemia.
Kwak JY; Ma TZ; Yoo MJ; Choi BH; Kim HG; Kim SR; Yim CY; Kwak YG
Exp Hematol; 2004 Sep; 32(9):836-42. PubMed ID: 15345285
[TBL] [Abstract][Full Text] [Related]
42. Identification of proteins involved in aggregation of human dermal papilla cells by proteomics.
Rushan X; Fei H; Zhirong M; Yu-Zhang W
J Dermatol Sci; 2007 Dec; 48(3):189-97. PubMed ID: 17875385
[TBL] [Abstract][Full Text] [Related]
43. Subcellular proteome analysis of camptothecin analogue NSC606985-treated acute myeloid leukemic cells.
Yu Y; Wang LS; Shen SM; Xia L; Zhang L; Zhu YS; Chen GQ
J Proteome Res; 2007 Sep; 6(9):3808-18. PubMed ID: 17655343
[TBL] [Abstract][Full Text] [Related]
44. Proteomics-based strategies to identify proteins relevant to chronic lymphocytic leukemia.
Alsagaby SA; Khanna S; Hart KW; Pratt G; Fegan C; Pepper C; Brewis IA; Brennan P
J Proteome Res; 2014 Nov; 13(11):5051-62. PubMed ID: 24983324
[TBL] [Abstract][Full Text] [Related]
45. [Two-dimensional electrophoresis and mass spectrometry analysis on effects of trichloroethylene on protein of L-02 liver cells].
Huang HY; Liu JJ; Zhuang ZX; Li XY; Xu XY; Wei QZ; Yang XH
Zhonghua Yu Fang Yi Xue Za Zhi; 2005 May; 39(3):175-8. PubMed ID: 15938849
[TBL] [Abstract][Full Text] [Related]
46. A chick retinal proteome database and differential retinal protein expressions during early ocular development.
Lam TC; Li KK; Lo SC; Guggenheim JA; To CH
J Proteome Res; 2006 Apr; 5(4):771-84. PubMed ID: 16602683
[TBL] [Abstract][Full Text] [Related]
47. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
[TBL] [Abstract][Full Text] [Related]
48. Proteomic classification of acute leukemias by alignment-based quantitation of LC-MS/MS data sets.
Foss EJ; Radulovic D; Stirewalt DL; Radich J; Sala-Torra O; Pogosova-Agadjanyan EL; Hengel SM; Loeb KR; Deeg HJ; Meshinchi S; Goodlett DR; Bedalov A
J Proteome Res; 2012 Oct; 11(10):5005-10. PubMed ID: 22900933
[TBL] [Abstract][Full Text] [Related]
49. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
Chung JC; Oh MJ; Choi SH; Bae CD
ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
[TBL] [Abstract][Full Text] [Related]
50. Performance of super-SILAC based quantitative proteomics for comparison of different acute myeloid leukemia (AML) cell lines.
Aasebø E; Vaudel M; Mjaavatten O; Gausdal G; Van der Burgh A; Gjertsen BT; Døskeland SO; Bruserud O; Berven FS; Selheim F
Proteomics; 2014 Sep; 14(17-18):1971-6. PubMed ID: 25044641
[TBL] [Abstract][Full Text] [Related]
51. Statistical detection of quantitative protein biomarkers provides insights into signaling networks deregulated in acute myeloid leukemia.
Elo LL; Karjalainen R; Ohman T; Hintsanen P; Nyman TA; Heckman CA; Aittokallio T
Proteomics; 2014 Nov; 14(21-22):2443-53. PubMed ID: 25211154
[TBL] [Abstract][Full Text] [Related]
52. [Differential proteomic analysis of human colorectal carcinoma cell lines SW620 and SW480 with different metastatic potentials].
Qu LJ; Ding YQ; Liang L
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1211-5, 1220. PubMed ID: 16234091
[TBL] [Abstract][Full Text] [Related]
53. Proteomics approaches for myeloid leukemia drug discovery.
Kapoor I; Pal P; Lochab S; Kanaujiya JK; Trivedi AK
Expert Opin Drug Discov; 2012 Dec; 7(12):1165-75. PubMed ID: 22971110
[TBL] [Abstract][Full Text] [Related]
54. Separation and identification of Musa acuminate Colla (banana) leaf proteins by two-dimensional gel electrophoresis and mass spectrometry.
Lu Y; Qi YX; Zhang H; Zhang HQ; Pu JJ; Xie YX
Genet Mol Res; 2013 Dec; 12(4):6871-81. PubMed ID: 24391035
[TBL] [Abstract][Full Text] [Related]
55. Comparative proteomics analysis on differentiation of human promyelocytic leukemia HL-60 cells into granulocyte and monocyte lineages.
Wang WJ; Tang W; Qiu ZY
Ai Zheng; 2009 Feb; 28(2):117-21. PubMed ID: 19550115
[TBL] [Abstract][Full Text] [Related]
56. The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and Perspectives.
Hernandez-Valladares M; Bruserud Ø; Selheim F
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957646
[TBL] [Abstract][Full Text] [Related]
57. Issues of processing and multiple testing of SELDI-TOF MS proteomic data.
Birkner MD; Hubbard AE; van der Laan MJ; Skibola CF; Hegedus CM; Smith MT
Stat Appl Genet Mol Biol; 2006; 5():Article11. PubMed ID: 16646865
[TBL] [Abstract][Full Text] [Related]
58. Freezing effects on the acute myeloid leukemia cell proteome and phosphoproteome revealed using optimal quantitative workflows.
Aasebø E; Mjaavatten O; Vaudel M; Farag Y; Selheim F; Berven F; Bruserud Ø; Hernandez-Valladares M
J Proteomics; 2016 Aug; 145():214-225. PubMed ID: 27107777
[TBL] [Abstract][Full Text] [Related]
59. Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients.
Aasebø E; Forthun RB; Berven F; Selheim F; Hernandez-Valladares M
Curr Pharm Biotechnol; 2016; 17(1):52-70. PubMed ID: 26306748
[TBL] [Abstract][Full Text] [Related]
60. Proteogenomics approaches for studying cancer biology and their potential in the identification of acute myeloid leukemia biomarkers.
Hernandez-Valladares M; Vaudel M; Selheim F; Berven F; Bruserud Ø
Expert Rev Proteomics; 2017 Aug; 14(8):649-663. PubMed ID: 28693350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
